Postural Drainage With and Without Aerobic Training on Chronic Suppurative Lung Disease

July 31, 2023 updated by: Riphah International University

Effects of Postural Drainage With and Without Aerobic Training on Respiratory Rate, Oxygen Saturation and Endurance in Chronic Suppurative Lung Disease

This will be a randomized controlled trial Patients will be divided into two groups randomly. Both groups will receive postural drainage as baseline treatment thrice a week for two weeks. The intervention group will undergo additional Aerobic Training thrice a week for two weeks as well along with postural drainage. Aerobic training will include a 5-step stair-climbing and a 10-step walk during each session. Data will be collected before and at the end of two weeks. Respiratory Rate, Pulse Oximeter, 10-meter Endurance walk test, and Pediatric Cough Questionnaire will be used to collect data pre and post-treatment. Data will be analyzed by use of SPSS Version 2010. Data will be presented in the form of mean and standard deviation.

Study Overview

Detailed Description

Chronic suppurative lung disease (csld) is a clinical syndrome in children with respiratory symptoms and signs. Children who have bronchiectasis symptoms but non-diagnostic scans are described as having chronic suppurative lung disease (csld). Postural drainage improves secretion clearance techniques, it is equally as effective as other airway clearance techniques. This study will focus on the implementation of postural drainage and aerobic training in this disease to find their effect on respiratory rate, oxygen saturation, and endurance.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab
      • Lahore, Punjab, Pakistan, 5400
        • Gulab Devi teaching hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 years to 13 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age of 5-13 years
  • Medically stable,
  • Patients must have 2 episodes of productive cough, each episode lasting for 4 weeks per year.

Exclusion Criteria:

  • Non-Chronic Suppurative Lung Disease related chronic disease
  • Chronic Suppurative Lung Disease-related conditions posing an increased risk to the patient when exercising.

children with any MSK-disorder or gait abnormalities

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Postural Drainage with Aerobic Training
The intervention group will undergo Postural Drainage and additional Aerobic Training thrice a week for two weeks as well along with postural drainage. Aerobic training will include a 5-step stair-climbing and 10-step walk during each session.
This will be a randomized controlled trial Patients will be divided into two groups randomly. Both groups will receive postural drainage as baseline treatment thrice a week for two weeks. The intervention group will undergo additional Aerobic Training thrice a week for two weeks as well along with postural drainage. Aerobic training will include 5-step stair-climbing and 10 step walk during each session.
Active Comparator: Postural Drainage
the group will receive postural drainage as baseline treatment thrice a week for two weeks.
Postural Drainage

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Respiratory Rate
Time Frame: 2 weeks
The respiratory rate is the rate at which breathing occurs; it is set and controlled by the respiratory center of the brain.
2 weeks
Oxygen Saturation
Time Frame: 2 Weeks
Oxygen saturation is the fraction of oxygen-saturated hemoglobin relative to total hemoglobin in the blood.
2 Weeks
10 Meter Walk Test
Time Frame: 2 Weeks
The individual is instructed to walk a set distance (6 meters, 10 meters, etc). Time is measured while the individual walks the set distance (often the individual is given space to accelerate to his/her preferred walking speed
2 Weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
5-item Pediatric Cough Questionnair
Time Frame: 2 Weeks
Used to measure frequency of child's cough with aa 6-point Likert-scale. Questionnair have 5 Questions to be answered by parent.
2 Weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Arnab Altaf, Mphill, Riphah International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2022

Primary Completion (Actual)

October 5, 2022

Study Completion (Actual)

December 5, 2022

Study Registration Dates

First Submitted

January 4, 2023

First Submitted That Met QC Criteria

March 15, 2023

First Posted (Actual)

March 16, 2023

Study Record Updates

Last Update Posted (Actual)

August 1, 2023

Last Update Submitted That Met QC Criteria

July 31, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • REC/RCR& AHS/22/0737

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lung Disease Chronic

Clinical Trials on Postural Drainge and aerobic training

Subscribe